But injectable HIV treatment could have a future in the global south, particularly when other long-acting products are developed, experts said at the 12th International AIDS Society Conference on HIV ...

A woman in New York City has no detectable HIV 14 months after stopping antiretroviral therapy following a transplant of HIV-resistant stem cells, according to a presentation yesterday at the C ...

A waxy substance, mostly made by the body and used to produce steroid hormones. High levels can be associated with atherosclerosis. There are two main types of cholesterol: low-density lipoprotein ...

Over half of funding for anti-gender actors in Europe appears to come from within Europe itself, with significant amounts of money also flowing from the US and the Russian Federation, according to ...

A widely used statin medication reduced the risk of heart attacks, strokes and other cardiovascular events when given to people with HIV who are at low to moderate risk for cardiovascular disease, ...

A man in southern California, dubbed the 'City of Hope patient', appears to be the latest person cured of HIV after receiving a stem cell transplant from a donor with a rare mutation, bringing the ...

Women can safely use the dapivirine vaginal ring for HIV pre-exposure prophylaxis (PrEP) in the third trimester of pregnancy and during breastfeeding, according to new studies presented this week at ...

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been providing life-changing information. Any donation you make helps us continue our work towards a world ...

It also found that both HIV prevalence and deaths were correlated negatively with the provision of antiretroviral therapy (ART). Whereas in a country with good ART provision, one would expect higher ...

South Africa is expected to begin piloting injectable pre-exposure prophylaxis (PrEP) in 2023, health financing mechanism Unitaid tells aidsmap. The demonstration study will be the first of many ...

Scientists from the pharmaceutical company Merck have published the first detailed data about a subset of the familiar non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs that, in addition to ...

In a session at the 24th International AIDS Conference (AIDS 2022) last week, priorities and lessons learnt from the harm reduction programmes for people who inject drugs in Africa were discussed by a ...